Japer Therapeutics, Inc. Warrants (JSPRW)
Since Nov 10, 2022, Japer Therapeutics, Inc. Warrants (JSPRW) has reported earnings 14 times. On average the shares move ±5.09% post-earnings, with a positive reaction 92.9% of the time. Its largest post-earnings gain was +0% (Aug 14, 2026) and its largest decline was -71.31% (May 12, 2023). The next earnings report is predicted for 2026-11-06 (approximate).
Earnings reactions
How JSPRW moved on each past earnings report.
Earnings Impact
Total Earnings
14
Avg Abs. Movement
±5.09%
Positive %
92.9%
Negative %
7.1%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| Aug 14, 2026 | ☽ POST | +0% | — |
| May 14, 2026 | ☽ POST | +0% | — |
| Mar 30, 2026 | ☽ POST | +0% | open_in_new |
| Nov 10, 2025 | ☀ PRE | +0% | open_in_new |
Earnings Count
14
Total earnings in dataset
Avg Abs. Movement
±5.09%
Avg % price change on earnings
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| DEF 14A | 20261019 | open_in_new SEC.gov |
| 8-K | 20261015 | open_in_new SEC.gov |
| S-3 | 20261014 | open_in_new SEC.gov |
| PRE 14A | 20261009 | open_in_new SEC.gov |
| 8-K | 20261007 | open_in_new SEC.gov |
| SC TO-I | 20261007 | open_in_new SEC.gov |
| 8-K/A | 20261005 | open_in_new SEC.gov |
| 8-K | 20261005 | open_in_new SEC.gov |
| 8-K/A | 20261001 | open_in_new SEC.gov |
| 8-K | 20260928 | open_in_new SEC.gov |
Frequently asked about JSPRW earnings
When does Japer Therapeutics, Inc. Warrants report earnings next? expand_more
Japer Therapeutics, Inc. Warrants (JSPRW)'s next earnings date is approximate for 2026-11-06. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does JSPRW stock move after earnings? expand_more
Over 14 reports, JSPRW has moved an average of ±5.09% the session after earnings, closing higher 92.9% of the time.
What was JSPRW's biggest post-earnings move? expand_more
JSPRW's largest post-earnings gain on record was +0% on Aug 14, 2026, and its largest decline was -71.31% on May 12, 2023.
Where can I find Japer Therapeutics, Inc. Warrants's SEC filings? expand_more
All of Japer Therapeutics, Inc. Warrants's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right
Reporting around the same time
- Aligos Therapeutics, Inc. Common Stock (ALGS) earnings 2026-11-05
- Allegiant Travel CO (ALGT) earnings 2026-11-03
- Alight, Inc. / Delaware (ALIT) earnings 2026-11-06
- Airbnb (ABNB) earnings 2026-11-05
- Arbutus Biopharma Corp (ABUS) earnings 2026-11-09
- Abacus Global Management, Inc. (ABX) earnings 2026-11-09
- Abacus Global Management, Inc. 9.875% Fixed Rate Senior Notes due 2028 (ABXL) earnings 2026-11-06
- ACADIA PHARMACEUTICALS INC (ACAD) earnings 2026-11-04